000 01310 a2200373 4500
005 20250518035120.0
264 0 _c20200810
008 202008s 0 0 eng d
022 _a1664-3224
024 7 _a10.3389/fimmu.2019.00774
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPio, Ruben
245 0 0 _aComplementing the Cancer-Immunity Cycle.
_h[electronic resource]
260 _bFrontiers in immunology
_c2019
300 _a774 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAnimals
650 0 4 _aAntineoplastic Agents, Immunological
_xpharmacology
650 0 4 _aBiomarkers, Tumor
650 0 4 _aComplement System Proteins
_ximmunology
650 0 4 _aDisease Susceptibility
_ximmunology
650 0 4 _aHumans
650 0 4 _aImmunity
650 0 4 _aImmunomodulation
650 0 4 _aLymphocyte Activation
_xgenetics
650 0 4 _aNeoplasms
_xdiagnosis
650 0 4 _aT-Lymphocytes
_ximmunology
700 1 _aAjona, Daniel
700 1 _aOrtiz-Espinosa, Sergio
700 1 _aMantovani, Alberto
700 1 _aLambris, John D
773 0 _tFrontiers in immunology
_gvol. 10
_gp. 774
856 4 0 _uhttps://doi.org/10.3389/fimmu.2019.00774
_zAvailable from publisher's website
999 _c29634432
_d29634432